These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

873 related articles for article (PubMed ID: 7691363)

  • 1. Incomplete reversal of beta-adrenoceptor desensitization in human and guinea-pig cardiomyocytes by cyclic nucleotide phosphodiesterase inhibitors.
    Wynne DG; Poole-Wilson PA; Harding SE
    Br J Pharmacol; 1993 Aug; 109(4):1071-8. PubMed ID: 7691363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pertussis toxin on beta-adrenoceptor responses in isolated cardiac myocytes from noradrenaline-treated guinea-pigs and patients with cardiac failure.
    Brown LA; Harding SE
    Br J Pharmacol; 1992 May; 106(1):115-22. PubMed ID: 1324064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic AMP levels in ventricular myocytes from noradrenaline-treated guinea-pigs.
    Wynne DG; Del Monte F; Harding SE
    Eur J Pharmacol; 1996 Aug; 310(2-3):235-42. PubMed ID: 8884222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
    von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Schmitz W; Scholz H; Starbatty J; Stein B; Wenzlaff H
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):90-100. PubMed ID: 1723153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
    Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H
    Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of phosphodiesterase inhibitor and isoproterenol in human and guinea-pig ventricular tissues and myocytes.
    Cheng PY; Lin CI; Lee FY; Chen YC; Lu HH
    Chin J Physiol; 1995; 38(3):185-91. PubMed ID: 8846728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic receptor stimulation and cyclic AMP-dependent effects in guinea-pig ventricular myocardium.
    Schmied R; Korth M
    Br J Pharmacol; 1990 Feb; 99(2):401-7. PubMed ID: 1691677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the cardiac actions of flosequinan in vitro.
    Gristwood RW; Beleta J; Bou J; Cardelús I; Fernández AG; Llenas J; Berga P
    Br J Pharmacol; 1992 Apr; 105(4):985-91. PubMed ID: 1324061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive inotropic activity of 5-amino-6-cyano-1,3-dimethyl-1,2,3,4-tetrahydropyrido[2,3-d]pyrim idine-2,4-dione in cardiac muscle from guinea-pig and man. Part 6: Compounds with positive inotropic activity.
    Heber D; Heers C; Ravens U
    Pharmazie; 1993 Jul; 48(7):537-41. PubMed ID: 7692456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of cyclic AMP in the positive inotropic effects of cyclic GMP-inhibited cyclic AMP phosphodiesterase inhibitors on guinea pig isolated left atria.
    Muller B; Lugnier C; Stoclet JC
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):444-51. PubMed ID: 1691369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
    Katano Y; Endoh M
    J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of cyclic AMP levels in primary cultures of human tracheal smooth muscle cells.
    Hall IP; Widdop S; Townsend P; Daykin K
    Br J Pharmacol; 1992 Oct; 107(2):422-8. PubMed ID: 1384913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of SK&F 94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human platelets.
    Simpson AW; Reeves ML; Rink TJ
    Biochem Pharmacol; 1988 Jun; 37(12):2315-20. PubMed ID: 2455518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of responses to a selective phosphodiesterase III inhibitor, SK&F 94120, on isolated myocardium, including human ventricular myocardium from "end-stage" failure patients.
    Gristwood RW; English TA; Wallwork J; Sampford KA; Owen DA
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):719-27. PubMed ID: 2442540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronotropic and inotropic actions of amrinone, carbazeran and isobutylmethyl xanthine: role of phosphodiesterase inhibition.
    Shahid M; Rodger IW
    Br J Pharmacol; 1989 Sep; 98(1):291-301. PubMed ID: 2478244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On minimum cyclic AMP formation rates associated with positive inotropic effects mediated through beta 1-adrenoceptors in kitten myocardium. Beta 1-specific and non-adrenergic stimulant effects of denopamine.
    Lemoine H; Teng KJ; Slee SJ; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):113-28. PubMed ID: 2566921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cAMP in the frequency-dependent changes in contraction of guinea-pig cardiomyocytes.
    Money-Kyrle AR; Davies CH; Ranu HK; O'Gara P; Kent NS; Poole-Wilson PA; Harding SE
    Cardiovasc Res; 1998 Feb; 37(2):532-40. PubMed ID: 9614507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noradrenaline-induced desensitization in cultured heart cells as a model for the defects of the adenylate cyclase system in severe heart failure.
    Reithmann C; Werdan K
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):138-44. PubMed ID: 2471084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase inhibition by naloxone augments the inotropic actions of beta-adrenergic stimulation.
    Park WK; Chang CH; Chae JE; Kim MH; Cho YL; Ahn DS
    Acta Anaesthesiol Scand; 2009 Sep; 53(8):1043-51. PubMed ID: 19572940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase inhibition in ventricular cardiomyocytes from guinea-pig hearts.
    Bethke T; Meyer W; Schmitz W; Scholz H; Stein B; Thomas K; Wenzlaff H
    Br J Pharmacol; 1992 Sep; 107(1):127-33. PubMed ID: 1384905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.